Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
Anaphylactic shock | Anaphylactic shock | x | x | |||
Angioedema | Angioedema | x | x | x | ||
Asthenia | Asthenia | x | x | x | ||
Cyanosis | Cyanosis | x | x | x | ||
Haemorrhage | Haemorrhage | x | x | x | ||
Haemoglobin | Haemorrhage | x | x | x | ||
Hypersensitivity | Hypersensitivity | x | x | |||
Nausea | Nausea | x | ||||
Pruritus | Pruritus | x | x | x | ||
Pulmonary oedema | Pulmonary oedema | x | x | x | ||
Hyperhidrosis | Sweating | x | x | x | ||
Urticaria | Urticaria | x | x | x | ||
Agitation | Agitation | x | x | x | ||
Tenderness | Tenderness | x | x | |||
Throat tightness | Throat tightness | x | x | x | ||
Induration | Induration | x | x | |||
Shock | Collapse | x | ||||
Feeling hot | Sensation of warmth | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |